OMX Nordic 40
2.328,27
PKT
-25,23
PKT
-1,07
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.12.23 | Ericsson (Telefon L.M.Ericsson) (B) Sell | Goldman Sachs Group Inc. | |
| 05.12.23 | Nokia Buy | Goldman Sachs Group Inc. | |
| 05.12.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.12.23 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 04.12.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 04.12.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 30.11.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 30.11.23 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 30.11.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 30.11.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 30.11.23 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 30.11.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 30.11.23 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 30.11.23 | Nokia Neutral | JP Morgan Chase & Co. | |
| 29.11.23 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 29.11.23 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 28.11.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 27.11.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 27.11.23 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 24.11.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 24.11.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.11.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 21.11.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 20.11.23 | AstraZeneca Overweight | Barclays Capital | |
| 20.11.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 20.11.23 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.11.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.11.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 16.11.23 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 15.11.23 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 10.11.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 09.11.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 08.11.23 | A.P. Moeller - Maersk A-S (B) Overweight | JP Morgan Chase & Co. | |
| 07.11.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 07.11.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 03.11.23 | A.P. Moeller - Maersk A-S (B) Buy | UBS AG | |
| 03.11.23 | A.P. Moeller - Maersk A-S (B) Sell | Goldman Sachs Group Inc. | |
| 03.11.23 | A.P. Moeller - Maersk A-S (B) Neutral | JP Morgan Chase & Co. | |
| 03.11.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.10.23 | AstraZeneca Overweight | JP Morgan Chase & Co. |